Prestige Consumer Healthcare EBIT

The latest EBIT for PBH is $280M as of June 2026. That compares with $330M in the prior-year period — down 15.8% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside Prestige Consumer Healthcare's historical trend and sector peers before judging valuation or financial health.

Over the past year, PBH's EBIT moved from $330M to $280M — a 15.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Prestige Consumer Healthcare's operating scale or balance-sheet position.

Against Healthcare companies, PBH currently prints $280M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Prestige Consumer Healthcare's growth, margins, and balance sheet.

A EBIT figure of $280M for PBH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting PBH's EBIT ($280M), review year-over-year change from $330M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.